Cargando…

Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?

Epinephrine given during cardiopulmonary resuscitation (CPR) may cause beta-mimetic complications in the postresuscitation phase. Vasopressin may be an alternative vasopressor drug during CPR. A subgroup analysis of a large prospective CPR investigation and of retrospective CPR studies suggests that...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzel, Volker, Lindner, Karl H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550833/
https://www.ncbi.nlm.nih.gov/pubmed/16542483
http://dx.doi.org/10.1186/cc4846
_version_ 1782129283828809728
author Wenzel, Volker
Lindner, Karl H
author_facet Wenzel, Volker
Lindner, Karl H
author_sort Wenzel, Volker
collection PubMed
description Epinephrine given during cardiopulmonary resuscitation (CPR) may cause beta-mimetic complications in the postresuscitation phase. Vasopressin may be an alternative vasopressor drug during CPR. A subgroup analysis of a large prospective CPR investigation and of retrospective CPR studies suggests that vasopressin may be especially beneficial when combined with epinephrine. Beneficial effects of adding vasopressin were observed in other catecholamine-refractory shock states as well, such as vasodilatory shock and haemorrhagic shock. In order to maximize effects of any vasopressor during CPR, rapid aggressive chest compressions must be ensured to maximize blood flow and to enable advanced cardiac life support drugs to reach the arterial vasculature. We suggest alternating injections of 1 mg epinephrine i.v. and 40 IU vasopressin i.v. every 3–5 minutes during CPR until spontaneous circulation can be achieved or CPR efforts are terminated.
format Text
id pubmed-1550833
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15508332006-08-22 Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future? Wenzel, Volker Lindner, Karl H Crit Care Commentary Epinephrine given during cardiopulmonary resuscitation (CPR) may cause beta-mimetic complications in the postresuscitation phase. Vasopressin may be an alternative vasopressor drug during CPR. A subgroup analysis of a large prospective CPR investigation and of retrospective CPR studies suggests that vasopressin may be especially beneficial when combined with epinephrine. Beneficial effects of adding vasopressin were observed in other catecholamine-refractory shock states as well, such as vasodilatory shock and haemorrhagic shock. In order to maximize effects of any vasopressor during CPR, rapid aggressive chest compressions must be ensured to maximize blood flow and to enable advanced cardiac life support drugs to reach the arterial vasculature. We suggest alternating injections of 1 mg epinephrine i.v. and 40 IU vasopressin i.v. every 3–5 minutes during CPR until spontaneous circulation can be achieved or CPR efforts are terminated. BioMed Central 2006 2006-02-22 /pmc/articles/PMC1550833/ /pubmed/16542483 http://dx.doi.org/10.1186/cc4846 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Commentary
Wenzel, Volker
Lindner, Karl H
Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title_full Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title_fullStr Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title_full_unstemmed Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title_short Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
title_sort vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550833/
https://www.ncbi.nlm.nih.gov/pubmed/16542483
http://dx.doi.org/10.1186/cc4846
work_keys_str_mv AT wenzelvolker vasopressincombinedwithepinephrineduringcardiacresuscitationasolutionforthefuture
AT lindnerkarlh vasopressincombinedwithepinephrineduringcardiacresuscitationasolutionforthefuture